Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 3
2010 5
2011 8
2012 5
2013 8
2014 6
2015 6
2016 9
2017 13
2018 13
2019 14
2020 11
2021 12
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

105 results
Results by year
Filters applied: . Clear all
Page 1
Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
J Gunderson A, Rajamanickam V, Bui C, Bernard B, Pucilowska J, Ballesteros-Merino C, Schmidt M, McCarty K, Philips M, Piening B, Dubay C, Medler T, Newell P, Hansen P, Tran E, Tang E, Bifulco C, Crittenden M, Gough M, Young KH. J Gunderson A, et al. Among authors: rajamanickam v. Oncoimmunology. 2021 Mar 17;10(1):1900635. doi: 10.1080/2162402X.2021.1900635. Oncoimmunology. 2021. PMID: 33796412 Free PMC article.
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells.
Duhen R, Ballesteros-Merino C, Frye AK, Tran E, Rajamanickam V, Chang SC, Koguchi Y, Bifulco CB, Bernard B, Leidner RS, Curti BD, Fox BA, Urba WJ, Bell RB, Weinberg AD. Duhen R, et al. Among authors: rajamanickam v. Nat Commun. 2021 Feb 16;12(1):1047. doi: 10.1038/s41467-021-21383-1. Nat Commun. 2021. PMID: 33594075 Free PMC article. Clinical Trial.
The Next Billion Users of Visualization.
Jena A, Butler M, Dwyer T, Ellis K, Engelke U, Kirkham R, Marriott K, Paris C, Rajamanickam V, Rhyne TM. Jena A, et al. Among authors: rajamanickam v. IEEE Comput Graph Appl. 2021 Mar-Apr;41(2):8-16. doi: 10.1109/MCG.2020.3044071. IEEE Comput Graph Appl. 2021. PMID: 33729921
Monitoring and control of E. coli cell integrity.
Kastenhofer J, Rajamanickam V, Libiseller-Egger J, Spadiut O. Kastenhofer J, et al. Among authors: rajamanickam v. J Biotechnol. 2021 Mar 10;329:1-12. doi: 10.1016/j.jbiotec.2021.01.009. Epub 2021 Jan 21. J Biotechnol. 2021. PMID: 33485861 Free article. Review.
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor.
Curti BD, Koguchi Y, Leidner RS, Rolig AS, Sturgill ER, Sun Z, Wu Y, Rajamanickam V, Bernard B, Hilgart-Martiszus I, Fountain CB, Morris G, Iwamoto N, Shimada T, Chang S, Traber PG, Zomer E, Horton JR, Shlevin H, Redmond WL. Curti BD, et al. Among authors: rajamanickam v. J Immunother Cancer. 2021 Apr;9(4):e002371. doi: 10.1136/jitc-2021-002371. J Immunother Cancer. 2021. PMID: 33837055 Free PMC article. Clinical Trial.
105 results